Japanese Foundation for Cancer Research
3 clinical trials · Sponsor
◉ Watch Japanese Foundation for Cancer Research
| Record | Firm | Date |
|---|---|---|
| Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA) (NCT07190443) | Japanese Foundation for Cancer Research | 2025-02-07 |
| A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer (NCT04732598) | Japanese Foundation for Cancer Research | 2021-01-21 |
| Safety Study of Multiple Peptide Vaccine to Esophageal Cancer (NCT00561275) | Japanese Foundation for Cancer Research | 2007-10-01 |
Track Japanese Foundation for Cancer Research automatically
Every clearance here is in the API, with alerts when new ones post.